Recent Study: Zimbabwe Pharmaceuticals & Healthcare Report Q2 2013
We continue to view Zimbabwe as one of the least promising markets globally. We also note that it is a market for which accurate data is very difficult to obtain, which is why we have decided not to forecast healthcare expenditure and pharmaceutical market subsector indicators, until reliable data from global bodies such as the World Health Organization (WHO) become available. In the meantime, foreign direct investment (FDI), urgently required to assist the stalled domestic pharmaceutical manufacturing industry activities, will...
View full press release